Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

• by Batool Zamani, Maedeh Najafizadeh, Atiye Jokar, Habibollah Rahimi, Hossein Motedayyen

• January 29, 2026

SARS-CoV-2 infection complicated by acute longitudinally extensive transverse myelitis and pulmonary embolism: a case report

• by Gulinazi Rouzi, Kamiernisa Wupuer, Ailiyaer Yasheng, Yang Liu, Reziya Apaer, Wumanjiang Yidayi, Taxi Wumiti, Pu Miao, Muhetaer Munire, Zhijian Li, Aizezi Aihemaitiniyazi

• May 1, 2026

Viral, Fungal Infections May Contribute to Nonresolving ARDS

Review links viral and fungal infections to persistent lung injury in nonresolving ARDS

• by Kerri Miller

• April 16, 2026

• 6 min

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

• by Anita Muglia, Daniele Petrone, Ilaria Schiavoni, Letizia Santinelli, Pasqualina Leone, Antonino Bella, Gabriella d’Ettorre, Francesco Alessandri, Anna Teresa Palamara, Claudio Maria Mastroianni, Paola Stefanelli, Giorgio Fedele

• May 25, 2026